Spero Therapeutics, Inc. (FRA:2HA)

Spero Therapeutics Statistics

Total Valuation

FRA:2HA has a market cap or net worth of EUR 110.01 million. The enterprise value is 71.07 million.

Market Cap	110.01M
Enterprise Value	71.07M

Important Dates

The next estimated earnings date is Friday, March 13, 2026.

Earnings Date	Mar 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	56.34M
Shares Outstanding	n/a
Shares Change (YoY)	+2.96%
Shares Change (QoQ)	+0.45%
Owned by Insiders (%)	2.03%
Owned by Institutions (%)	20.26%
Float	46.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.18
PB Ratio	4.87
P/TBV Ratio	4.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.90
EV / Sales	2.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.83, with a Debt / Equity ratio of 0.13.

Current Ratio	3.83
Quick Ratio	3.74
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -95.29% and return on invested capital (ROIC) is -56.38%.

Return on Equity (ROE)	-95.29%
Return on Assets (ROA)	-29.77%
Return on Invested Capital (ROIC)	-56.38%
Return on Capital Employed (ROCE)	-111.29%
Revenue Per Employee	1.08M
Profits Per Employee	-1.17M
Employee Count	32
Asset Turnover	0.43
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:2HA has paid 247,167 in taxes.

Income Tax	247,167
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +87.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+87.67%
50-Day Moving Average	1.89
200-Day Moving Average	1.53
Relative Strength Index (RSI)	50.63
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.96

Income Statement

In the last 12 months, FRA:2HA had revenue of EUR 34.56 million and -37.36 million in losses. Loss per share was -0.67.

Revenue	34.56M
Gross Profit	-18.04M
Operating Income	-38.43M
Pretax Income	-37.11M
Net Income	-37.36M
EBITDA	-38.43M
EBIT	-38.43M
Loss Per Share	-0.67

Balance Sheet

The company has 41.44 million in cash and 2.86 million in debt, giving a net cash position of 38.58 million.

Cash & Cash Equivalents	41.44M
Total Debt	2.86M
Net Cash	38.58M
Net Cash Per Share	n/a
Equity (Book Value)	22.58M
Book Value Per Share	0.40
Working Capital	32.96M

Cash Flow

Operating Cash Flow	-23.59M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is -52.19%, with operating and profit margins of -111.21% and -108.11%.

Gross Margin	-52.19%
Operating Margin	-111.21%
Pretax Margin	-107.39%
Profit Margin	-108.11%
EBITDA Margin	-111.20%
EBIT Margin	-111.21%
FCF Margin	n/a

Dividends & Yields

FRA:2HA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.96%
Shareholder Yield	-2.96%
Earnings Yield	-33.96%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:2HA has an Altman Z-Score of -11.9 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-11.9
Piotroski F-Score	2